![](https://hndb0f.p3cdn1.secureserver.net/wp-content/uploads/2024/02/Photo-11.jpg?time=1725536250)
Semaglutide
Semaglutide is a medication classified as a GLP-1 (glucagon-like peptide-1) receptor agonist initially approved for patients with type 2 diabetes in adjunct with diet and exercise. The drug essentially mimics the endogenous peptide
Semaglutide is a medication classified as a GLP-1 (glucagon-like peptide-1) receptor agonist initially approved for patients with type 2 diabetes in adjunct with diet and exercise. The drug essentially mimics the endogenous peptide